Log In
BCIQ
Print this Print this
 

EML4-ALK assay, ExoDx Lung ALK (EXO501a)

  Manage Alerts
Collapse Summary General Information
Company Exosome Diagnostics Inc.
DescriptionNon-invasive, liquid biopsy test to isolate and analyze exosomal RNA from a blood sample to detect EML4-ALK mutation and oncogenic fusion protein transcripts
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect EML4-ALK mutation and oncogenic fusion protein transcripts in patients with non-small cell lung cancer (NSCLC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/09/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today